Dalila Darmoul

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Development of kallikrein-related peptidase 7 (KLK7) inhibitors and use in a species-adapted model for ovarian cancer.

Development of kallikrein-related peptidase 7 (KLK7) inhibitors and use in a species-adapted model for ovarian cancer.

Journal: Biological chemistry
Published: December 19, 2025

KLK7 overexpression promotes an aggressive phenotype and facilitates peritoneal dissemination in colorectal cancer cells.

KLK7 overexpression promotes an aggressive phenotype and facilitates peritoneal dissemination in colorectal cancer cells.

Journal: FEBS open bio
Published: July 18, 2025

Kallikrein-Related Peptidase 6 Contributes to Murine Intestinal Tumorigenesis Driven by a Mutant Adenomatous polyposis coli Gene.

Kallikrein-Related Peptidase 6 Contributes to Murine Intestinal Tumorigenesis Driven by a Mutant Adenomatous polyposis coli Gene.

Journal: Cancers
Published: October 29, 2024

Kallikrein-Related Peptidase 6 (KLK6) as a Contributor toward an Aggressive Cancer Cell Phenotype: A Potential Role in Colon Cancer Peritoneal Metastasis.

Kallikrein-Related Peptidase 6 (KLK6) as a Contributor toward an Aggressive Cancer Cell Phenotype: A Potential Role in Colon Cancer Peritoneal Metastasis.

Journal: Biomolecules
Published: May 12, 2022

Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer.

Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer.

Journal: Genes
Published: April 01, 2021

Insights into the activity control of the kallikrein-related peptidase 6: small-molecule modulators and allosterism.

Insights into the activity control of the kallikrein-related peptidase 6: small-molecule modulators and allosterism.

Journal: Biological chemistry
Published: December 28, 2017

Kallikrein-related peptidase 7 overexpression in melanoma cells modulates cell adhesion leading to a malignant phenotype.

Kallikrein-related peptidase 7 overexpression in melanoma cells modulates cell adhesion leading to a malignant phenotype.

Journal: Biological chemistry
Published: December 28, 2017

Advanced high-grade serous ovarian cancer: inverse association of KLK13 and KLK14 mRNA levels in tumor tissue and patients' prognosis.

Advanced high-grade serous ovarian cancer: inverse association of KLK13 and KLK14 mRNA levels in tumor tissue and patients' prognosis.

Journal: Journal of cancer research and clinical oncology
Published: December 21, 2017

Aberrant expression of kallikrein-related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion.

Aberrant expression of kallikrein-related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion.

Journal: Molecular oncology
Published: February 21, 2017

Kallikrein-related peptidase 7 (KLK7) is a proliferative factor that is aberrantly expressed in human colon cancer.

Kallikrein-related peptidase 7 (KLK7) is a proliferative factor that is aberrantly expressed in human colon cancer.

Journal: Biological chemistry
Published: February 15, 2014

Kallikrein-related peptidase signaling in colon carcinoma cells: targeting proteinase-activated receptors.

Kallikrein-related peptidase signaling in colon carcinoma cells: targeting proteinase-activated receptors.

Journal: Biological chemistry
Published: October 18, 2011
Showing 1-11 of 11

Last Updated: 09/26/2026